Please login to the form below

Not currently logged in
Email:
Password:

Chiltern International lines up Dr Jim Esinhart as next CEO

He will replace Glenn Kerkhof from November 1, 2012

Chiltern International has selected Dr Jim Esinhart to be its next CEO with effect from November 1, 2012.

He will replace Glenn Kerkhof, who is stepping down as CEO of the London-based contract research organisation (CRO) after six years in the post.

Kerkhof will relocate to his native Australia to lead Chiltern's owner Czura Thornton in Asia Pacific, but will join Chiltern's board of directors.

Chiltern's new CEO Dr Esinhart has been with the company for six years and is currently senior executive vice president of global scientific services.

Kerkhof said: “I am delighted to have played my part in the development of Chiltern as a leading mid-tier CRO. Chiltern now employs more than 1,400 people in 34 countries, is financially very strong and is poised for substantial growth.

“I am also delighted to see the CEO position transition to a valued and trusted colleague in Jim Esinhart, who I know will bring a tremendous amount to the role. And I very much look forward to contributing to Chiltern's future as a member of the Board based in the Asia Pacific region.”

9th October 2012

From: PME

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics